biote Corp. (BTMD)
1.47
-0.04
(-2.65%)
USD |
NASDAQ |
Sep 09, 16:00
1.47
0.00 (0.00%)
After-Hours: 18:09
biote EPS Diluted (Quarterly) : -0.2293 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2293 |
| March 31, 2026 | 0.0633 |
| December 31, 2025 | 0.0634 |
| September 30, 2025 | 0.223 |
| June 30, 2025 | 0.1003 |
| March 31, 2025 | 0.3712 |
| December 31, 2024 | 0.0993 |
| September 30, 2024 | 0.3317 |
| June 30, 2024 | -0.2143 |
| March 31, 2024 | -0.1202 |
| December 31, 2023 | 0.1221 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.2426 |
| June 30, 2023 | -0.2484 |
| March 31, 2023 | -0.387 |
| December 31, 2022 | 0.0276 |
| September 30, 2022 | 0.002 |
| June 30, 2022 | -0.3441 |
| March 31, 2022 | 0.038 |
| December 31, 2021 | -0.0297 |
| September 30, 2021 | 0.9318 |
| June 30, 2021 | 1.065 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cannabis Strategic Ventures, Inc. | 0.00 |
| Rafael Holdings, Inc. | -0.0825 |
| Concentra Group Holdings Parent, Inc. | 0.5003 |
| Elite Health Systems, Inc. | -0.0537 |
| U.S. Stem Cell, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.428M |
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 50.80M |
| Enterprise Value | 166.84M |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | -16.79% |
| Earnings Yield | 8.19% |
| Operating Earnings Yield | 45.48% |
| Normalized Earnings Yield | 13.56 |